Shanghai Fosun Pharmaceutical (Group) Co Ltd (SFOSF)
1.695
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
Shanghai Fosun Pharmaceutical Total Assets (Quarterly): 15.98B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.98B |
| December 31, 2023 | 16.01B |
| September 30, 2023 | 15.18B |
| June 30, 2023 | 15.46B |
| June 30, 2023 | 15.46B |
| March 31, 2023 | 15.60B |
| December 31, 2022 | 15.53B |
| September 30, 2022 | 14.64B |
| June 30, 2022 | 14.74B |
| June 30, 2022 | 14.74B |
| March 31, 2022 | 15.06B |
| December 31, 2021 | 14.64B |
| September 30, 2021 | 13.95B |
| June 30, 2021 | 13.69B |
| June 30, 2021 | 13.69B |
| March 31, 2021 | 13.16B |
| December 31, 2020 | 12.81B |
| September 30, 2020 | 11.80B |
| June 30, 2020 | 11.31B |
| June 30, 2020 | 11.31B |
| March 31, 2020 | 10.91B |
| December 31, 2019 | 10.88B |
| September 30, 2019 | 11.03B |
| June 30, 2019 | 10.70B |
| June 30, 2019 | 10.70B |
| Date | Value |
|---|---|
| March 31, 2019 | 10.84B |
| December 31, 2018 | 10.31B |
| September 30, 2018 | 9.962B |
| June 30, 2018 | 9.987B |
| June 30, 2018 | 9.987B |
| March 31, 2018 | 10.13B |
| December 31, 2017 | 9.492B |
| September 30, 2017 | 8.476B |
| June 30, 2017 | 7.460B |
| June 30, 2017 | 7.460B |
| March 31, 2017 | 6.870B |
| December 31, 2016 | 6.302B |
| September 30, 2016 | 6.333B |
| June 30, 2016 | 6.168B |
| June 30, 2016 | 6.168B |
| March 31, 2016 | 6.126B |
| December 31, 2015 | 5.885B |
| September 30, 2015 | 5.879B |
| June 30, 2015 | 5.851B |
| June 30, 2015 | 5.851B |
| March 31, 2015 | 5.702B |
| December 31, 2014 | 5.697B |
| September 30, 2014 | 5.404B |
| June 30, 2014 | 4.991B |
| June 30, 2014 | 4.991B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.70B
Minimum
Jun 2019
16.01B
Maximum
Dec 2023
13.56B
Average
13.95B
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 13.66B |
| CASI Pharmaceuticals Inc | 58.01M |
| Zai Lab Ltd | 988.44M |
| Gracell Biotechnologies Inc (DELISTED) | 259.03M |
| Adagene Inc | 115.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.899B |
| Shareholders Equity (Quarterly) | 6.513B |
| Debt to Equity Ratio | 0.7098 |
| Current Ratio | 1.007 |
| Net Debt Paydown Yield | -1.55% |